Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases"
IJU Case Rep
.
2024 Nov 12;8(1):9-10.
doi: 10.1002/iju5.12805.
eCollection 2025 Jan.
Author
Manabu Kato
1
Affiliation
1
Department of Urology Aichi Cancer Center Hospital Nagoya Aichi Japan.
PMID:
39749297
PMCID:
PMC11693093
DOI:
10.1002/iju5.12805
No abstract available
Publication types
Editorial